We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On the same day that it published its second report on monitoring of patent settlements in the EU, the parties settled a live case that the EC had been investigating in the area
On Aug. 13, 2012, the Federal Trade Commission (FTC) announced proposed changes to the premerger notification rules that would require pharmaceutical companies to report proposed acquisitions of exclusive patent rights
